Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
September 28, 2024
Markers of Metabolic Abnormalities in Vitiligo Patients
Federica Papaccio, Monica Ottaviani, Mauro Truglio, et al.
Dermatologic Therapy
|
July 10, 2019
Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism
Kory Schrom, Alessia Pacifico, Ruzica R Z Conic, et al.
International Journal of STD & AIDS
|
September 11, 2023
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series
Diego Orsini, Fabio S Maramao, Luigi Gargiulo, et al.
Cells
|
April 25, 2025
Defective Intracellular Insulin/IGF-1 Signaling Elucidates the Link Between Metabolic Defect and Autoimmunity in Vitiligo
Silvia Caputo, Federica Papaccio, Ramona Marrapodi, et al.
Cells
|
November 26, 2022
A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
Federica Papaccio, Barbara Bellei, Monica Ottaviani, et al.
Science Advances
|
September 2, 2022
Altered epidermal proliferation, differentiation, and lipid composition: Novel key elements in the vitiligo puzzle
Daniela Kovacs, Emanuela Bastonini, Stefania Briganti, et al.
Dermatologic Therapy
|
February 2, 2021
Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics
Giovanni Damiani, Laura Cristina Gironi, Khalaf Kridin, et al.
Dermatologic Therapy
|
December 6, 2018
When IL-17 inhibitors fail: Real-life evidence to switch from secukinumab to adalimumab or ustekinumab
Giovanni Damiani, Rosalynn R Z Conic, Valerio de Vita, et al.
The Journal of Dermatological Treatment
|
June 8, 2023
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
Diego Orsini, Luigi Gargiulo, Luciano Ibba, et al.
World Journal of Clinical Cases
|
April 8, 2020
Gut microbiota and nutrient interactions with skin in psoriasis: A comprehensive review of animal and human studies
Giovanni Damiani, Nicola Luigi Bragazzi, Thomas S McCormick, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
September 28, 2024
Markers of Metabolic Abnormalities in Vitiligo Patients
Federica Papaccio, Monica Ottaviani, Mauro Truglio, et al.
Dermatologic Therapy
|
July 10, 2019
Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism
Kory Schrom, Alessia Pacifico, Ruzica R Z Conic, et al.
International Journal of STD & AIDS
|
September 11, 2023
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series
Diego Orsini, Fabio S Maramao, Luigi Gargiulo, et al.
Cells
|
April 25, 2025
Defective Intracellular Insulin/IGF-1 Signaling Elucidates the Link Between Metabolic Defect and Autoimmunity in Vitiligo
Silvia Caputo, Federica Papaccio, Ramona Marrapodi, et al.
Cells
|
November 26, 2022
A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
Federica Papaccio, Barbara Bellei, Monica Ottaviani, et al.
Science Advances
|
September 2, 2022
Altered epidermal proliferation, differentiation, and lipid composition: Novel key elements in the vitiligo puzzle
Daniela Kovacs, Emanuela Bastonini, Stefania Briganti, et al.
Dermatologic Therapy
|
February 2, 2021
Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics
Giovanni Damiani, Laura Cristina Gironi, Khalaf Kridin, et al.
Dermatologic Therapy
|
December 6, 2018
When IL-17 inhibitors fail: Real-life evidence to switch from secukinumab to adalimumab or ustekinumab
Giovanni Damiani, Rosalynn R Z Conic, Valerio de Vita, et al.
The Journal of Dermatological Treatment
|
June 8, 2023
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
Diego Orsini, Luigi Gargiulo, Luciano Ibba, et al.
World Journal of Clinical Cases
|
April 8, 2020
Gut microbiota and nutrient interactions with skin in psoriasis: A comprehensive review of animal and human studies
Giovanni Damiani, Nicola Luigi Bragazzi, Thomas S McCormick, et al.
Page
of 7